Hosted on MSN22h
Alphamab doses first subject in trial of JSKN003 for ovarian cancer
Alphamab Oncology has dosed the first subject in the randomised Phase III JSKN003-306 trial of its anti-human epidermal ...
FiercePharma22h
FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout
A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...
The American Journal of Managed Care4h
Pursuit of ADCs in Bladder Cancer Comes With Questions About Toxicity, Cost
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...
The American Journal of Managed Care16h
Analysis Looks at Benefits, Toxicity of ADC Combinations in Advanced Bladder Cancer
Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.
What's on Netflix23h
Welcome to What's on Netflix
Betty Gilpin is the latest to join the cast for the new romantic comedy.